FIELD: medicine.
SUBSTANCE: present invention relates to a method for treating extensive superficial lesions of the skin, including, against the background of drug therapy, topical application of an effective amount of a drug, which is used as an agent containing ingredients, in wt %: hydroxypropyl cellulose 5.0; lidocaine hydrochloride, calculated as anhydrous substance 5.0; 2-allyloxyethanol 4.0; nipagin (methyl parahydroxybenzoate) 0.15; nipazole (propyl parahydroxybenzoate) 0.05; purified water 85.8.
EFFECT: increasing efficiency and reducing the duration of treatment.
1 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING LOCAL MANIFESTATIONS OF HERPEX SIMPLEX INFECTIONS AND FOR PREVENTING INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS | 2013 |
|
RU2514103C1 |
AGENT FOR TREATING EXTENSIVE SKIN SURFACE INJURIES, INCLUDING ALL TYPES OF BURNS | 2019 |
|
RU2733512C2 |
OPIOID RECEPTOR ANTAGONIST (NALTREXONE) APPLICABLE IN THERAPY OF HERPES ZOSTER | 2011 |
|
RU2561871C2 |
GEL, POSSESSING ANTI- INFLAMMATORY AND ANTIALLERGIC EFFECT | 2008 |
|
RU2370265C1 |
COMPOUND OF AVERMECTIN FAMILY OR OF MILBEMYCIN FAMILY FOR TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS | 2014 |
|
RU2669942C1 |
AVERMECTIN OR MILBEMYCIN FAMILY COMPOUND FOR TREATMENT AND/OR PREVENTION OF ADOPIC DERMATITIS | 2014 |
|
RU2792693C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING SKIN ITCHING | 2012 |
|
RU2543326C2 |
METHOD FOR TREATMENT OF SKIN DISORDERS | 2012 |
|
RU2583137C2 |
SULFUR OINTMENT | 1994 |
|
RU2112505C1 |
METHOD FOR TREATING PATIENTS AT KAPOSI'S ECZEMA HERPETICUM AT DEVELOPING CONVERSION DISORDER | 2006 |
|
RU2320345C1 |
Authors
Dates
2021-06-09—Published
2019-04-30—Filed